PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-02-14

Date Title Company
14-Feb-2026 INVESTOR ALERT: Ultragenyx Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces Businesswire